MedTrace Logo

Management of Post-circumcision Ischemia Using Hyperbaric Oxygen Therapy

NCT05152511 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2021-12-10

No results posted yet for this study

Summary

Background: Post-circumcision penile ischaemia is a rare but destructive complication. Our goal is to present our experience in the management of children, who had different forms of penile ischaemia, complicating the routine ritual male circumcision.

Material and Methods: All male children who had post-circumcision penile ischaemia between April 2017 and October 2020 were included in the study. A special designed protocol for management of all cases includes a combination of early Pentoxifylline intervenes infusion with Hyperbaric Oxygen inhalation, early catheterization, and appropriate surgical debridement. Data were analyzed inclusively to patient age, the anesthesia method used, Monopolar diathermy usage, early presentation, method of circumcision and positive wound culture.

Conditions

  • Post-circumsion Complications

Interventions

COMBINATION_PRODUCT

Hyperbaric oxygen therapy

Hyperbaric oxygen therapy is a specially designed cabinet for infants and neonates with a barometric pressure equal to 760 mmHg for 20 minutes daily, then gradually increase up to one hour daily for 5 days per week (fig. 1). The chamber was kept warm. The babies were fed before entering the chamber and if signs of hunger appear during therapy. The baby was continuously monitored with pulse oximeter. Older children are managed in the conventional Hyperbaric oxygen chamber with the same regimen.

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • Sarah M Abdelmohsen · Aswan University

Eligibility

Min Age
1 Month
Max Age
6 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152511 on ClinicalTrials.gov